• MDM1 Overexpression Enhances CRC Chemoradiotherapy via p53 R

  2026-07-21

  This study demonstrates that elevated MDM1 expression improves colorectal cancer cell sensitivity to chemoradiotherapy by upregulating p53 and promoting apoptosis. These findings identify MDM1 as a mechanistically relevant biomarker and suggest strategies for overcoming therapy resistance in CRC.

• Single-Cell Functional Profiling with Nanovials for Cell The

  2026-07-21

  The referenced dissertation presents a nanovial-based, high-throughput platform for single-cell functional profiling of unconventional T cells and CAR T cell libraries. This innovation enables direct linkage of TCR or CAR sequence to antigen specificity and function, offering a powerful discovery pipeline for next-generation cell therapies.

• C8-HSL Drives Lung Cancer Progression via PI3K/AKT/ERK Activ

  2026-07-20

  This study demonstrates that the bacterial quorum-sensing molecule N-octanoyl-L-Homoserine lactone (C8-HSL) directly enhances lung cancer cell proliferation, migration, and invasion by activating the PI3K/AKT/ERK pathway. The findings establish a mechanistic link between Gram-negative bacterial signaling and tumor progression, revealing new translational targets for infection biology and microbial pathogenicity research.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Opt

  2026-07-20

  DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) enables precision targeting of chloride channel function, unlocking new opportunities in cancer, vascular, and neuroprotection studies. Advanced protocols and troubleshooting strategies maximize DIDS’s impact in dissecting tumor biology and neuronal survival, as demonstrated by recent breakthroughs in metastasis modeling and ion transport modulation.

• Bordetella BteA Effector Drives IL-1Ra via Akt/mTOR: Mechani

  2026-07-19

  This study uncovers how the Bordetella type III secretion system effector BteA manipulates host epithelial-eosinophil signaling to promote IL-1Ra expression, facilitating bacterial persistence. Mechanistically, BteA activates the Akt/mTOR pathway to upregulate IL-1Ra, providing new therapeutic targets for combatting chronic respiratory infections.

• Spatially Targeted mTORC1 Inhibition Reveals Nuclear Functio

  2026-07-18

  This study introduces TerminaTOR, a genetically encoded tool enabling precise subcellular inhibition of mTORC1, and reveals a distinct role for nuclear mTORC1 in transcriptional regulation. The findings advance understanding of the compartmentalized PI3K/Akt/mTOR pathway and open new avenues for dissecting spatial signaling in cancer and cell biology.

• JAK2/STAT1 Pathway in Diuron-Induced Acute Renal Injury

  2026-07-17

  This study integrates network toxicology, transcriptomics, and in vitro assays to reveal that Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute kidney injury via JAK2/STAT1 pathway activation. These findings provide mechanistic insight critical for environmental risk assessment and future toxicology workflows.

• MK-571 (L-660,711): Optimizing Inflammation and Drug Resista

  2026-07-17

  MK-571 (L-660,711) unlocks precise control over leukotriene-mediated inflammation and multidrug resistance in advanced immune cell models. This article translates recent mechanistic breakthroughs into actionable protocols and troubleshooting strategies, enabling researchers to maximize assay clarity and reliability.

• Hepatic sEH Regulates Osteoclastogenesis via Nrf2 in Osteopo

  2026-07-16

  A recent study uncovers that hepatic soluble epoxide hydrolase (sEH) promotes osteoclast differentiation by suppressing the Nrf2 signaling pathway, establishing a direct mechanistic link between liver-derived lipid metabolism and bone health. These findings reveal a novel liver-bone axis in osteoporosis and underscore the translational value of targeting sEH and fatty acid epoxide signaling for chronic inflammation and bone disease research.

• Scenario-Driven Solutions with DiscoveryProbe™ Bioactive Com

  2026-07-16

  This article addresses real-world challenges in biomedical research, focusing on cell viability, pathway screening, and assay reproducibility. Leveraging the DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P), we demonstrate validated, data-backed workflows and practical decision-making for high-throughput screening and pathway analysis.

• Etoposide (VP-16): Precision Design for DNA Damage Assays

  2026-07-15

  Explore how Etoposide (VP-16) empowers precision DNA damage assays and apoptosis research. This article delivers new insights for optimizing experimental design and interpreting cytotoxicity in cancer models.

• CD36-Driven Lipid Uptake Promotes Immune Escape in AML

  2026-07-15

  Guo et al. reveal that acute myeloid leukemia (AML) cells utilize a non-canonical, CD36-dependent lipid metabolism program to suppress T cell function and resist hypomethylating agent therapy. These findings highlight the interplay between lipid metabolism and immune evasion in AML, offering new directions for translational therapeutics.

• SEC-seq Reveals VEGF-A Secretion Heterogeneity in MSCs

  2026-07-14

  The referenced study introduces SEC-seq, a single-cell platform that links secretory activity to transcriptomic profiles in mesenchymal stromal cells (MSCs). This work uncovers marked heterogeneity in VEGF-A secretion, identifies unique gene expression signatures in high-secreting subpopulations, and highlights key technical advances for profiling secretory function at single-cell resolution.

• Fluconazole as a Fungal Cytochrome P450 Enzyme 14α-Demethyla

  2026-07-14

  Fluconazole from APExBIO stands out as a precision antifungal tool for dissecting fungal pathogenesis, resistance, and membrane biochemistry. This article delivers actionable protocols, troubleshooting insights, and a comparative research edge—especially in Candida albicans infection models and antifungal susceptibility testing.

• GDC-0068 (RG7440): Pan-AKT Inhibition Redefines PI3K/Akt/mTO

  2026-07-13

  Explore the advanced science behind GDC-0068 (RG7440), a pan-AKT inhibitor that enables precise dissection of the PI3K/Akt/mTOR pathway. This article delves into new spatial insights and practical assay guidance for researchers seeking breakthrough understanding of Akt signaling.

16564 records 1/1105 page Next 12345 下5页 Last page